CN Stock MarketDetailed Quotes

Tongling Jieya Biologic Technology (301108)

Watchlist
  • 27.45
  • -0.23-0.83%
Market Closed Apr 17 15:00 CST
3.09BMarket Cap39.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tongling Jieya Biologic Technology (301108) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
41.02%772.01M
38.44%564.78M
8.79%310.13M
-4.62%123.65M
-12.07%547.45M
-8.79%407.97M
1.99%285.07M
1.43%129.64M
-6.60%622.59M
-14.91%447.27M
Operating revenue
41.02%772.01M
38.44%564.78M
8.79%310.13M
-4.62%123.65M
-12.07%547.45M
-8.79%407.97M
1.99%285.07M
1.43%129.64M
-6.60%622.59M
-14.91%447.27M
Other operating revenue
14.50%9.19M
----
37.04%4.89M
----
-73.41%8.03M
----
-80.55%3.57M
----
65.43%30.2M
----
Total operating cost
33.10%678.04M
29.03%497.53M
5.62%279.78M
-4.84%118.17M
-0.80%509.4M
6.06%385.58M
20.49%264.89M
32.12%124.19M
0.21%513.52M
-2.48%363.56M
Operating cost
30.84%575.65M
28.48%422.27M
3.45%236.22M
-5.09%99.23M
0.42%439.98M
7.38%328.67M
22.01%228.34M
31.10%104.56M
-4.09%438.15M
-12.80%306.09M
Operating tax surcharges
29.92%5.45M
39.09%4.2M
35.83%3.19M
11.52%1.42M
-36.13%4.19M
-25.23%3.02M
-6.24%2.35M
13.67%1.28M
35.21%6.57M
20.64%4.04M
Operating expense
-32.42%6.4M
-32.62%5.11M
-43.46%2.81M
-48.70%1.31M
-2.01%9.47M
-8.78%7.58M
33.96%4.98M
69.06%2.55M
34.86%9.66M
107.14%8.31M
Administration expense
35.18%60.97M
26.11%47.64M
14.55%29.25M
-1.27%11.99M
-7.12%45.1M
3.01%37.78M
14.33%25.53M
10.82%12.14M
38.08%48.56M
59.24%36.67M
Financial expense
114.04%1.38M
60.28%-2.52M
54.73%-2.84M
25.89%-1.2M
17.75%-9.82M
32.12%-6.35M
12.03%-6.28M
63.53%-1.62M
29.28%-11.94M
66.22%-9.36M
-Interest expense (Financial expense)
81.13%1.39M
43.84%771.41K
-71.57%116.92K
-55.61%92.23K
-23.90%769.02K
-17.02%536.3K
-88.71%411.26K
-22.31%207.75K
-45.80%1.01M
-54.21%646.28K
-Interest Income (Financial expense)
-7.08%-7.87M
15.08%-5.66M
38.39%-3.51M
31.58%-1.58M
38.05%-7.35M
17.44%-6.67M
37.24%-5.7M
26.92%-2.31M
6.45%-11.86M
53.92%-8.08M
Research and development
37.67%28.19M
40.02%20.84M
11.84%11.15M
2.67%5.42M
-9.07%20.48M
-16.44%14.88M
-11.57%9.97M
3.64%5.28M
-10.96%22.52M
-6.72%17.81M
Credit Impairment Loss
-61.99%-13.06M
-610.15%-3.52M
-356.79%-1.2M
-126.02%-427.23K
-810.54%-8.06M
-27.36%690.79K
-12.75%467.03K
-41.70%1.64M
239.33%1.14M
158.17%951.02K
Asset Impairment Loss
39.51%-17.04M
-50.88%-2.6M
23.17%-1.06M
248.84%680.82K
-135.21%-28.17M
-233.20%-1.73M
-283.98%-1.38M
290.86%195.17K
-158.37%-11.98M
92.73%-517.79K
Other net revenue
46.39%-7.3M
-40.42%9.83M
-35.33%6.16M
-52.51%4.34M
-152.84%-13.62M
-26.06%16.5M
-34.73%9.52M
1.35%9.13M
46.56%25.78M
855.56%22.31M
Fair value change income
-49.59%5.35M
-48.94%3.69M
-41.26%2.47M
-60.52%985.56K
17.12%10.61M
53.76%7.22M
111.05%4.2M
970.18%2.5M
795.57%9.06M
213.11%4.7M
Invest income
41.84%11.09M
12.24%8.07M
-33.99%2.89M
-55.30%1.7M
-57.79%7.82M
-42.79%7.19M
-53.55%4.38M
-15.59%3.8M
55.44%18.52M
563.12%12.57M
-Including: Investment income associates
97.59%-269.42K
87.46%-1M
73.32%-1.46M
-38.94%-1.29M
-1,281.28%-11.19M
---7.98M
---5.49M
---927.09K
---810.05K
----
Asset deal income
1,309.23%360.92K
657.61%166.43K
661.85%167.7K
2,652.73%167.7K
-109.34%-29.85K
70.45%-29.85K
-77.37%-29.85K
-52.71%6.09K
-72.18%319.55K
-312.96%-101.01K
Other revenue
42.39%6M
28.03%4.03M
53.35%2.89M
23.90%1.23M
-51.63%4.22M
-33.21%3.15M
-37.30%1.89M
-35.86%994.39K
-2.74%8.72M
-41.15%4.72M
Operating profit
254.81%86.67M
98.21%77.08M
22.90%36.51M
-32.68%9.82M
-81.88%24.43M
-63.32%38.89M
-60.00%29.71M
-65.94%14.58M
-21.48%134.85M
-29.26%106.02M
Add:Non operating Income
-58.97%647.79K
-19.41%1.09M
-52.36%646.38K
-99.38%7.3K
277.76%1.58M
246.56%1.36M
674.90%1.36M
13,888.41%1.17M
-43.16%417.93K
-37.51%391.83K
Less:Non operating expense
-14.33%737.06K
-8.80%667.23K
-1.75%661.97K
-82.64%107.04K
230.96%860.33K
234.06%731.6K
528.04%673.78K
66,115.10%616.75K
-97.48%259.95K
-90.45%219K
Total profit
244.32%86.58M
96.15%77.5M
20.09%36.5M
-35.81%9.72M
-81.37%25.15M
-62.79%39.51M
-59.12%30.39M
-64.65%15.14M
-16.75%135.01M
-28.35%106.2M
Less:Income tax cost
53.74%9.18M
91.42%9.46M
1.22%3.94M
-126.13%-331.26K
-70.82%5.97M
-62.65%4.94M
-58.33%3.89M
-77.22%1.27M
-3.46%20.46M
-31.37%13.24M
Net profit
303.68%77.4M
96.82%68.04M
22.86%32.56M
-27.55%10.05M
-83.26%19.17M
-62.81%34.57M
-59.23%26.5M
-62.77%13.87M
-18.75%114.54M
-27.90%92.96M
Net profit from continuing operation
303.68%77.4M
96.82%68.04M
22.86%32.56M
-27.55%10.05M
-83.26%19.17M
-62.81%34.57M
-59.23%26.5M
-62.77%13.87M
-18.75%114.54M
-27.90%92.96M
Less:Minority Profit
145.58%132.42K
218.53%136.43K
69.76%-27.54K
56.36%-12.8K
55.71%-290.52K
81.26%-115.1K
16.71%-91.06K
-280.73%-29.33K
---655.9K
---614.36K
Net profit of parent company owners
296.97%77.27M
95.78%67.9M
22.55%32.58M
-27.61%10.06M
-83.10%19.46M
-62.94%34.68M
-59.16%26.59M
-62.70%13.9M
-18.28%115.2M
-27.42%93.58M
Earning per share
Basic earning per share
300.00%0.68
39.53%0.6
21.21%0.4
-23.53%0.13
-88.03%0.17
-62.61%0.43
-58.75%0.33
-63.04%0.17
-18.39%1.42
-27.67%1.15
Diluted earning per share
300.00%0.68
39.53%0.6
21.21%0.4
-23.53%0.13
-88.03%0.17
-62.61%0.43
-58.75%0.33
-63.04%0.17
-18.39%1.42
-27.67%1.15
Other composite income
-50.05K
-568.24K
-140.77K
Other composite income of parent company owners
---50.05K
---568.24K
---140.77K
----
----
----
----
----
----
----
Total composite income
303.42%77.35M
95.18%67.47M
22.33%32.42M
-27.55%10.05M
-83.26%19.17M
-62.81%34.57M
-59.23%26.5M
-62.77%13.87M
-18.75%114.54M
-27.90%92.96M
Total composite income of parent company owners
296.72%77.22M
94.14%67.33M
22.02%32.44M
-27.61%10.06M
-83.10%19.46M
-62.94%34.68M
-59.16%26.59M
-62.70%13.9M
-18.28%115.2M
-27.42%93.58M
Total composite income of minority owners
145.58%132.42K
218.53%136.43K
69.76%-27.54K
56.36%-12.8K
55.71%-290.52K
81.26%-115.1K
16.71%-91.06K
-280.73%-29.33K
---655.9K
---614.36K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
--
--
Rongcheng Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue 41.02%772.01M38.44%564.78M8.79%310.13M-4.62%123.65M-12.07%547.45M-8.79%407.97M1.99%285.07M1.43%129.64M-6.60%622.59M-14.91%447.27M
Operating revenue 41.02%772.01M38.44%564.78M8.79%310.13M-4.62%123.65M-12.07%547.45M-8.79%407.97M1.99%285.07M1.43%129.64M-6.60%622.59M-14.91%447.27M
Other operating revenue 14.50%9.19M----37.04%4.89M-----73.41%8.03M-----80.55%3.57M----65.43%30.2M----
Total operating cost 33.10%678.04M29.03%497.53M5.62%279.78M-4.84%118.17M-0.80%509.4M6.06%385.58M20.49%264.89M32.12%124.19M0.21%513.52M-2.48%363.56M
Operating cost 30.84%575.65M28.48%422.27M3.45%236.22M-5.09%99.23M0.42%439.98M7.38%328.67M22.01%228.34M31.10%104.56M-4.09%438.15M-12.80%306.09M
Operating tax surcharges 29.92%5.45M39.09%4.2M35.83%3.19M11.52%1.42M-36.13%4.19M-25.23%3.02M-6.24%2.35M13.67%1.28M35.21%6.57M20.64%4.04M
Operating expense -32.42%6.4M-32.62%5.11M-43.46%2.81M-48.70%1.31M-2.01%9.47M-8.78%7.58M33.96%4.98M69.06%2.55M34.86%9.66M107.14%8.31M
Administration expense 35.18%60.97M26.11%47.64M14.55%29.25M-1.27%11.99M-7.12%45.1M3.01%37.78M14.33%25.53M10.82%12.14M38.08%48.56M59.24%36.67M
Financial expense 114.04%1.38M60.28%-2.52M54.73%-2.84M25.89%-1.2M17.75%-9.82M32.12%-6.35M12.03%-6.28M63.53%-1.62M29.28%-11.94M66.22%-9.36M
-Interest expense (Financial expense) 81.13%1.39M43.84%771.41K-71.57%116.92K-55.61%92.23K-23.90%769.02K-17.02%536.3K-88.71%411.26K-22.31%207.75K-45.80%1.01M-54.21%646.28K
-Interest Income (Financial expense) -7.08%-7.87M15.08%-5.66M38.39%-3.51M31.58%-1.58M38.05%-7.35M17.44%-6.67M37.24%-5.7M26.92%-2.31M6.45%-11.86M53.92%-8.08M
Research and development 37.67%28.19M40.02%20.84M11.84%11.15M2.67%5.42M-9.07%20.48M-16.44%14.88M-11.57%9.97M3.64%5.28M-10.96%22.52M-6.72%17.81M
Credit Impairment Loss -61.99%-13.06M-610.15%-3.52M-356.79%-1.2M-126.02%-427.23K-810.54%-8.06M-27.36%690.79K-12.75%467.03K-41.70%1.64M239.33%1.14M158.17%951.02K
Asset Impairment Loss 39.51%-17.04M-50.88%-2.6M23.17%-1.06M248.84%680.82K-135.21%-28.17M-233.20%-1.73M-283.98%-1.38M290.86%195.17K-158.37%-11.98M92.73%-517.79K
Other net revenue 46.39%-7.3M-40.42%9.83M-35.33%6.16M-52.51%4.34M-152.84%-13.62M-26.06%16.5M-34.73%9.52M1.35%9.13M46.56%25.78M855.56%22.31M
Fair value change income -49.59%5.35M-48.94%3.69M-41.26%2.47M-60.52%985.56K17.12%10.61M53.76%7.22M111.05%4.2M970.18%2.5M795.57%9.06M213.11%4.7M
Invest income 41.84%11.09M12.24%8.07M-33.99%2.89M-55.30%1.7M-57.79%7.82M-42.79%7.19M-53.55%4.38M-15.59%3.8M55.44%18.52M563.12%12.57M
-Including: Investment income associates 97.59%-269.42K87.46%-1M73.32%-1.46M-38.94%-1.29M-1,281.28%-11.19M---7.98M---5.49M---927.09K---810.05K----
Asset deal income 1,309.23%360.92K657.61%166.43K661.85%167.7K2,652.73%167.7K-109.34%-29.85K70.45%-29.85K-77.37%-29.85K-52.71%6.09K-72.18%319.55K-312.96%-101.01K
Other revenue 42.39%6M28.03%4.03M53.35%2.89M23.90%1.23M-51.63%4.22M-33.21%3.15M-37.30%1.89M-35.86%994.39K-2.74%8.72M-41.15%4.72M
Operating profit 254.81%86.67M98.21%77.08M22.90%36.51M-32.68%9.82M-81.88%24.43M-63.32%38.89M-60.00%29.71M-65.94%14.58M-21.48%134.85M-29.26%106.02M
Add:Non operating Income -58.97%647.79K-19.41%1.09M-52.36%646.38K-99.38%7.3K277.76%1.58M246.56%1.36M674.90%1.36M13,888.41%1.17M-43.16%417.93K-37.51%391.83K
Less:Non operating expense -14.33%737.06K-8.80%667.23K-1.75%661.97K-82.64%107.04K230.96%860.33K234.06%731.6K528.04%673.78K66,115.10%616.75K-97.48%259.95K-90.45%219K
Total profit 244.32%86.58M96.15%77.5M20.09%36.5M-35.81%9.72M-81.37%25.15M-62.79%39.51M-59.12%30.39M-64.65%15.14M-16.75%135.01M-28.35%106.2M
Less:Income tax cost 53.74%9.18M91.42%9.46M1.22%3.94M-126.13%-331.26K-70.82%5.97M-62.65%4.94M-58.33%3.89M-77.22%1.27M-3.46%20.46M-31.37%13.24M
Net profit 303.68%77.4M96.82%68.04M22.86%32.56M-27.55%10.05M-83.26%19.17M-62.81%34.57M-59.23%26.5M-62.77%13.87M-18.75%114.54M-27.90%92.96M
Net profit from continuing operation 303.68%77.4M96.82%68.04M22.86%32.56M-27.55%10.05M-83.26%19.17M-62.81%34.57M-59.23%26.5M-62.77%13.87M-18.75%114.54M-27.90%92.96M
Less:Minority Profit 145.58%132.42K218.53%136.43K69.76%-27.54K56.36%-12.8K55.71%-290.52K81.26%-115.1K16.71%-91.06K-280.73%-29.33K---655.9K---614.36K
Net profit of parent company owners 296.97%77.27M95.78%67.9M22.55%32.58M-27.61%10.06M-83.10%19.46M-62.94%34.68M-59.16%26.59M-62.70%13.9M-18.28%115.2M-27.42%93.58M
Earning per share
Basic earning per share 300.00%0.6839.53%0.621.21%0.4-23.53%0.13-88.03%0.17-62.61%0.43-58.75%0.33-63.04%0.17-18.39%1.42-27.67%1.15
Diluted earning per share 300.00%0.6839.53%0.621.21%0.4-23.53%0.13-88.03%0.17-62.61%0.43-58.75%0.33-63.04%0.17-18.39%1.42-27.67%1.15
Other composite income -50.05K-568.24K-140.77K
Other composite income of parent company owners ---50.05K---568.24K---140.77K----------------------------
Total composite income 303.42%77.35M95.18%67.47M22.33%32.42M-27.55%10.05M-83.26%19.17M-62.81%34.57M-59.23%26.5M-62.77%13.87M-18.75%114.54M-27.90%92.96M
Total composite income of parent company owners 296.72%77.22M94.14%67.33M22.02%32.44M-27.61%10.06M-83.10%19.46M-62.94%34.68M-59.16%26.59M-62.70%13.9M-18.28%115.2M-27.42%93.58M
Total composite income of minority owners 145.58%132.42K218.53%136.43K69.76%-27.54K56.36%-12.8K55.71%-290.52K81.26%-115.1K16.71%-91.06K-280.73%-29.33K---655.9K---614.36K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Rongcheng Certified Public Accountants (Special General Partnership)------Rongcheng Certified Public Accountants (Special General Partnership)------Rongcheng Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +1.04%
Sample Name
Sample Code
 -4.60%
Sample Name
Sample Code
 -6.30%
4
CNOOC
00883
-6.32%
5
YANCHANG PETRO
00346
-8.99%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.87%
Sample Name
Sample Code
 +10.97%
Sample Name
Sample Code
 +6.23%
4
INESA Intelligent Tech Inc.
600602
+6.13%
5
Business-intelligence Of Oriental Nations Corporation
300166
+1.83%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -